Avalo Therapeutics (AVTX) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Avalo Therapeutics (AVTX) over the last 12 years, with Q3 2025 value amounting to $210000.0.
- Avalo Therapeutics' Other Non-Current Assets rose 6030.53% to $210000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $210000.0, marking a year-over-year increase of 6030.53%. This contributed to the annual value of $131000.0 for FY2024, which is 0.0% changed from last year.
- As of Q3 2025, Avalo Therapeutics' Other Non-Current Assets stood at $210000.0, which was up 6030.53% from $210000.0 recorded in Q2 2025.
- In the past 5 years, Avalo Therapeutics' Other Non-Current Assets ranged from a high of $1.0 million in Q4 2021 and a low of $131000.0 during Q4 2022
- Over the past 5 years, Avalo Therapeutics' median Other Non-Current Assets value was $131000.0 (recorded in 2022), while the average stood at $204736.8.
- Per our database at Business Quant, Avalo Therapeutics' Other Non-Current Assets skyrocketed by 57114.09% in 2021 and then tumbled by 8690.0% in 2022.
- Avalo Therapeutics' Other Non-Current Assets (Quarter) stood at $1.0 million in 2021, then plummeted by 86.9% to $131000.0 in 2022, then changed by 0.0% to $131000.0 in 2023, then changed by 0.0% to $131000.0 in 2024, then skyrocketed by 60.31% to $210000.0 in 2025.
- Its Other Non-Current Assets was $210000.0 in Q3 2025, compared to $210000.0 in Q2 2025 and $131000.0 in Q1 2025.